Philadelphia Inquirer reports that
The Bush administration’s opposition to emergency contraception seems to be doing wonders for awareness and use of the method…
Annual prescriptions for Barr Laboratories’ brand, Plan B, have doubled to 1.6 million during the two years that Food and Drug Administration leaders have refused to approve nonprescription sales of the product. FDA advisers and staff, as well as major medical organizations, have endorsed over-the-counter sales.